What do we treat        

    

The electric stimulations are applied for treatment of the following diseases: 1. Treatment of vision disorders: various genesis optic nerve atrophy optic nerve (underdevelopment) hypoplasia I-II stage open-angle glaucoma with normalized intraocular pressure pigmental retina degeneration (and other inherited retina dystrophies) diplopia (paralytic strabismus) amblyopia ("lazy eye") progressive myopia The most significant results are achieved when treating small children with optic nerve hypoplasia. Totally blind children acquire the object vision by means of electric stimulations which enables them to be independent in everyday life. It is desirable to begin applying the electric stimulations up to the child 1-st year. Thanks to the application of the electric stimulations, the field of vision of the patients with glaucoma is enlarged, the “mist” before the eyes is decreased, the disease progress is either slowed down or stopped at all.   2. Treatment of hearing disorder of children and adults: sensorineural deafness (hearing loss) mixed form of deafness (combination of sensorineural deafness with inner ear lesion otosclerosis (cochlear form) The treatment efficiency will be within 70-85% range depending upon the disease term and the hearing function reduction degree. The treatment of deafness of any degree by the method invented by A.N. Shandurina, professor, will enable to improve the hearing functions and to prevent the disease progress. Sooner the treatment started then there is more probability to regain the hearing functions. The most impressive results to improve the hearing disorders are obtained when treating children with the ES- thus contributing to their active speech development, to the improvement of psycho-physiologic adaptation in the social medium. We were witnesses of several cases when, having the hearing function reduction to a greater extent, the sound perception was restored to the normal characteristics. 3. Treatment of nervous system diseases in the form of movement disorders, sensitivity disturbances, memory impairment, disturbances of speech, emotional sphere and thinking caused by: consequences of cranio-cerebral injuries parkinsonism cerebral stroke after effects dysc i rculatory encephalopathies neur o infections consequences of the brain tumor removal consequences of hydrocephaly or hypertensive syndrome disseminated sclerosis perinatal brain pathology epilepsy The unique nature of the ES treatment of epilepsy involves a selective activation of the brain structures inhibiting the brain epileptic readiness. C ontradictions against the method application: when there is uncompensated glaucoma with high values of intraocular pressure (IOP) - over 27 mm Hg (in cases when it is required to treat the vision disorder) when there are non-operated malignant tumors and in cases of tumor continued growth in the after-operation period psychos e s when there are acute infections and inflammatory diseases availability of hemodynamically-significant stenoses of brain great vessels Method efficiency: for 70-80% of the patients, treated by the method, progress of the disease becomes suspended and its manifestations become reduced. Patients with epilepsy lose the disease fits in 30% of the cases, following the first course of the treatment and, in some 40-50% of the cases, the fits become rare and light. The positive results of the electric stimulation application are preserved and they are even enhanced during the next 3-4 months after the ES, due to improvement of the conductivity and excitability of the nervous system and to improvement of circulation and metabolic processes at the cellular level. The results of the most common disease treatment are represented hereafter. Treatment of vision disorders •  glaucoma treatment – 75% improvement •  optic nerve hypoplasia -80% improvement •  pigmental retina degeneration – 68% improvement •  diplopia treatment – 70% improvement •  optic nerve atrophy – 70% improvement Treatment of hearing disorders •  treatment of sensorineural deafness - 63% improvement, •  treatment of sensorineural deafness and lesion of the inner ear – 77.5% improvement Treatment of nervous system diseases •  treatment of cranio-cerebral injury consequences - 87% improvement: reduction of headache fits and intensity of asthenia •  treatment of brain stroke consequences -72% improvement: strength increase in limbs, improvement of speech, memory •  treatment of parkinsonism - 83% improvement: reduction of rigidity and akinesia, tremor reduction, confidence when walking, disease progress stop •  treatment of dyscirculatory encephalopathies - 95% improvement: vertigo decrease and unsteadiness while walking, normalization of sleep •  treatment of hydrocephaly and hypertensive syndrome consequences - 87% improvement; reduction of headaches •  treatment of disseminated sclerosis - 58% improvement: decrease of vestibulopathy, decrease of evidence of limb paresis (incomplete paralysis), improvement of pelvis functioning •  treatment of infantile cerebral paralysis (ICP) and other consequences of perinatal pathology - 72% improvement: speech and intellect development, growth of strength in the muscles of arms, legs and neck •  treatment of epilepsy - 70-80% improvement: reduction and diminution of fit intensity, reduction of therapeutic dose of anticonvulsants Treatment of vision disorders •  glaucoma treatment – 75% improvement •  optic nerve hypoplasia -80% improvement •  pigmental retina degeneration – 68% improvement •  diplopia treatment – 70% improvement •  optic nerve atrophy – 70% improvement Treatment of hearing disorders •  treatment of sensorineural deafness - 63% improvement, •  treatment of sensorineural deafness and lesion of the inner ear – 77.5% improvement Treatment of nervous system diseases •  treatment of cranio-cerebral injury consequences - 87% improvement: reduction of headache fits and intensity of asthenia •  treatment of brain stroke consequences -72% improvement: strength increase in limbs, improvement of speech, memory •  treatment of parkinsonism - 83% improvement: reduction of rigidity and akinesia, tremor reduction, confidence when walking, disease progress stop •  treatment of dyscirculatory encephalopathies - 95% improvement: vertigo decrease and unsteadiness while walking, normalization of sleep •  treatment of hydrocephaly and hypertensive syndrome consequences - 87% improvement; reduction of headaches •  treatment of disseminated sclerosis - 58% improvement: decrease of vestibulopathy, decrease of evidence of limb paresis (incomplete paralysis), improvement of pelvis functioning •  treatment of infantile cerebral paralysis (ICP) and other consequences of perinatal pathology - 72% improvement: speech and intellect development, growth of strength in the muscles of arms, legs and neck •  treatment of epilepsy - 70-80% improvement: reduction and diminution of fit intensity, reduction of therapeutic dose of anticonvulsants   Statistics figures of Percutanenous Electrical Stimulations (PES)Method Improvement or the Method Efficiency when treating VISION , HEARING , NERVOUS SYSTEM DISORDERS